On August 13, 2021, the Food and Drug Administration (FDA) granted approval for Belzutifan, mar…
On August 15, 2023, the Food and Drug Administration (FDA) granted accelerated approval to Entr…
Lung cancer remains a formidable health challenge, particularly when advanced to a stage where …
Enhertu trastuzumab deruxtecan was given regular approval for the treatment of adults with unre…
A randomized, open-label phase 3 trial (LITESPARK-005, ClinicalTrials.gov, NCT04195750) investi…
Gilead’s Sciences announced the promising activity of Trodelvy (sacituzumab govitecan-hziy) i…
The clinical trial HER2CLIMB-02 conducted on Tukysa (Tucatinib) in combination with Kadycyla…
B-cell Acute lymphoblastic leukemia (B-cell ALL) is an aggressive type of blood cancer and is v…